Clinical and Social Trajectories of Children and Adolescents With Disruptive Behavior
NCT ID: NCT02812537
Last Updated: 2023-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2019-05-20
2028-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Care management of children and adolescents admitted for disruptive behaviors in emergency rooms is an issue. No consensus or official recommendation exists. However, use of emergency care in this context is increasing in most western countries and it exposes to several risks (inappropriate use of hospitalizations, social rupture, ignorance of comorbidities and suicide risk). The Trajectories project is designed to describe children and adolescents with disruptive behaviors, their care management and to follow their life trajectory and psychiatric evolution after admission to emergency rooms. Better understanding this population will improve their medical and social care management, thereby giving professionals the right tools.
The main objective of this project is to implement a multidisciplinary and integrative research combining clinical considerations and social sciences to determine the "trajectory" of this population.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical and Social Trajectory of Children and Adolescents With Disruptive Behavior
NCT02828969
Study of Children at Risk for Disruptive Behavior Disorders
NCT00001233
Predictive Factors for the Outcome of Young Children Emotional and/or Behavioral Disorders After Psychotherapeutic Intervention
NCT05820269
Treatment of Conduct Problems and Depression
NCT01267773
Psychiatric Future of Young Patients Hospitalized in the Pass'Aje Service Between 2006 and 2010
NCT03309670
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with conduct disorders
Girls and boys having less than 16 years old and admitted to emergency room for aggressiveness, violence, fugue or theft.
patients with conduct disorders
interview with a specialist
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
patients with conduct disorders
interview with a specialist
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children and adolescents admitted to emergency rooms for aggressiveness, violence, fugue or theft
Exclusion Criteria
* Opposition to the subject or the family to participate to this research
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yannis Gansel, MD
Role: PRINCIPAL_INVESTIGATOR
Hospices Cicils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospices Civils de Lyon
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yannis Gansel, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL16_0136
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.